Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma

Fig. 3

A 53-year male treated by DEB-TACE for advanced primary HCC. A MRI preoperative examination revealed a large tumor of 61.2*48.5 mm in right liver. B-C The tumor artery was superselectively incubated and embolized by 300-500 μm raltitrexed-loaded beads. D MRI revealed a shrunk tumor 1.2 months later. E A small tumor was found and embolized. F The tumor was found to shrink after 8.0 months' follow-up, and still alive after 34.0 months

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us